Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-21-005458

Options or other derivatives

  • President and CEO acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KOCH KEVIN President and CEO 2021-08-17 Grant or award · Stock Option (Right to Buy) +400,000 400,000 D: show line 1 in the form
Loading xslF345X03/primarydocument.xml…